Nabriva Therapeutics PLC (NASDAQ:NBRV)
| 1.29 Delayed Data As of Feb 27 |  -0.08 / -5.84%Today’s Change | 1.16 Today|||52-Week Range 3.27 | -2.27% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Schroeder Theodore R Chief Executive Officer |  Buy | 8/27/2019 | 50,000 | $1.79 | $89.5K | -28.33% |
Schroeder Theodore R Chief Executive Officer |  Sale | 1/31/2020 | 16,276 | $1.35 | $22.0K | -4.44% |
Broom Colin Director | Sale | 8/21/2019 | 10,177 | $2.07 | $21.1K | -37.07% |
Broom Colin Director | Sale | 8/21/2019 | 10,177 | $2.07 | $21.1K | -37.07% |
Broom Colin Director | Buy | 8/30/2019 | 10,177 | $2.03 | $20.7K | -36.14% |
Gelone Steven P President & Chief Operating Officer | Sale | 1/31/2020 | 8,651 | $1.35 | $11.7K | -4.44% |
Gelone Steven P President & Chief Operating Officer | Sale | 8/21/2019 | 4,816 | $2.08 | $10.0K | -37.07% |
Gelone Steven P President & Chief Operating Officer | Sale | 8/21/2019 | 4,816 | $2.08 | $10.0K | -37.07% |
Lavino Francesco Maria Chief Commercial Officer | Buy | 8/22/2019 | 4,800 | $2.04 | $9.8K | -37.68% |
Lavino Francesco Maria Chief Commercial Officer | Sale | 8/21/2019 | 3,797 | $2.08 | $7.9K | -37.07% |
Page of 4